Drug targets for cognitive enhancement in neuropsychiatric disorders

Keyphrases

• Cognitive Enhancement 100%
• Alzheimer's Disease 100%
• Neuropsychiatric Disorders 100%
• Drug Target 100%
• Cognitive Deficits 66%
• Clinical Development 66%
• Cognitive Impairment Associated with Schizophrenia 66%
• Treatment Options 33%
• Cognitive Impairment 33%
• Clinical Trials 33%
• Down Syndrome 33%
• Cognitive Function 33%
• New Therapies 33%
• Central Nervous System 33%
• Working Memory 33%
• Sleep Deprivation 33%
• Attention Deficit Hyperactivity Disorder 33%
• Psychiatric Disorders 33%
• Neurodegenerative Diseases 33%
• Signaling Pathway 33%
• Schizophrenia 33%
• Neurological Disorders 33%
• Aging Population 33%
• Disease Syndrome 33%
• Novel Therapeutic Targets 33%
• Preclinical Development 33%
• System Research 33%
• Glutamatergic 33%
• Nicotinic Agonists 33%
• Neurotransmission 33%
• Phosphodiesterase 33%
• Serotonergic 33%
• Cell Surface Receptor 33%
• Long-term Memory Formation 33%
• Inverse Agonist 33%
• Neuropsychiatric Conditions 33%
• Alpha4 33%
• Preclinical Experiment 33%
• Cholinergic Receptors 33%
• Narcolepsy 33%
• Histamine H3 Receptor 33%
• Sleep Center 33%
• Glycine Transporter Inhibitor 33%
• Inhibitory Tone 33%
• GABAA 33%
• 5-HT Agonist 33%
• Proof of Concept Study 33%

INIS

• drugs 100%
• nervous system diseases 100%
• receptors 75%
• investigations 50%
• sleep 50%
• diseases 25%
• therapy 25%
• humans 25%
• brain 25%
• clinical trials 25%
• animals 25%
• populations 25%
• central nervous system 25%
• aging 25%
• phosphodiesterases 25%
• downs syndrome 25%
• surfaces 25%
• glycine 25%
• histamine 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Cognitive Defect 100%
• Alzheimer's Disease 60%
• Isoetarine 20%
• Clinical Trial 20%
• Phosphodiesterase 20%
• Serotonin Agonist 20%
• 4 Aminobutyric Acid 20%
• Attention Deficit Disorder 20%
• Down Syndrome 20%
• Degenerative Disease 20%
• Cholinergic Receptor 20%
• Cell Surface Receptor 20%
• Nicotinic Agent 20%
• Inverse Agonist 20%
• Histamine H3 Receptor Antagonist 20%
• Glycine Transporter 20%
• Serotonin Antagonist 20%
• Narcolepsy 20%
• Diseases 20%